A $200M capital raise reduces funding risks as Austal embarks on a A$1B+ capex spend over the next two to three years. The prize for successful execution will be a decade or more of visibility under a significant pipeline. Dilution reduces our valuation 5% to $4.40 (prior $4.65), and we downgrade to HOLD (prior BUY) based off the last traded price.
To access the full report please log in under the Research Portal at the bottom of this page.
Argonaut’s Research Portal allows you to access Argonaut’s wealth of Research, as well as view the Morning Note, an overview of the Companies covered and the Team.
If you would like to access our research please contact us to create an account.
